Vimarsana
Biggest News Aggregation in the World

Forecast Insight News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Forecast Insight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Forecast Insight Today - Breaking & Trending Today

Research and Markets: Hepatocellular Carcinoma Epidemiology Forecast to 2029: Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China - Vimarsana News

Research and Markets: Hepatocellular Carcinoma Epidemiology Forecast to 2029: Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China

Research and Markets: Hepatocellular Carcinoma Epidemiology Forecast to 2029: Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China - ResearchAndMarkets.com ResearchAndMarkets.com's offering. The Hepatocellular Carcinoma (HCC) Epidemiology Report provides an overview of the risk factors and the global and historical trends for HCC in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China). The report includes the diagnosed incident cases and five-year diagnosed prevalent cases of HCC in these markets from 2019-2029. Hepatocellular carcinom...

Global Rheumatoid Arthritis Epidemiology Forecast to 2029 – ResearchAndMarkets.com - Vimarsana News

Global Rheumatoid Arthritis Epidemiology Forecast to 2029 – ResearchAndMarkets.com

ResearchAndMarkets.com’s offering. RA is the result of an immune response in which the body’s immune system attacks its own healthy cells, especially the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response (Centers for Disease Control and Prevention, 2020). The disease can lead to premature mortality, disability, and decreased quality of life due to bone erosion and joint deformity (Brooks, 2006; Centers for Disease Control and Prevention, 2020). The epidemiologists utilized county-specific studies published in peer-reviewed journals to buil...

$27.2 Billion Non-Alcoholic Steatohepatitis (NASH) Opportunity Analysis and Forecasts to 2029 – ResearchAndMarkets.com - Vimarsana News

$27.2 Billion Non-Alcoholic Steatohepatitis (NASH) Opportunity Analysis and Forecasts to 2029 – ResearchAndMarkets.com

ResearchAndMarkets.com’s offering. Sales for the NASH market to grow from $144.4M in 2019 to $27.2B in 2029 at a Compound Annual Growth Rate (CAGR) of 68.8% across the 7MM. At the end of 2029, the US will contribute around 94.3% of global sales, while the 5EU and Japan will account for around 4.5% and 1.2% of sales, respectively. Non-alcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of steatosis (fatty liver), in addition to liver inflammation and damage. Unlike alcoholic liver disease, NASH occurs in those who drink little or ...